Display options
Cite
Hofmann HM, Weiss PA, Haas JG. Continuous insulin delivery systems for the pregnant diabetic patient. Acta Diabetol Lat. 1986;23(3):201-14doi: 10.1007/BF02624706.
Hofmann, H. M., Weiss, P. A., & Haas, J. G. (1986). Continuous insulin delivery systems for the pregnant diabetic patient. Acta diabetologica latina, 23(3), 201-14. https://doi.org/10.1007/BF02624706
Hofmann, H M, et al. "Continuous insulin delivery systems for the pregnant diabetic patient." Acta diabetologica latina vol. 23,3 (1986): 201-14. doi: https://doi.org/10.1007/BF02624706
Hofmann HM, Weiss PA, Haas JG. Continuous insulin delivery systems for the pregnant diabetic patient. Acta Diabetol Lat. 1986 Jul-Sep;23(3):201-14. doi: 10.1007/BF02624706. PMID: 3788406.
Copy Download .nbib Format: NLM
Share it on

Acta Diabetol Lat. 1986 Jul-Sep;23(3):201-14. doi: 10.1007/BF02624706.

Continuous insulin delivery systems for the pregnant diabetic patient.

Acta diabetologica latina

H M Hofmann, P A Weiss, J G Haas

PMID: 3788406 DOI: 10.1007/BF02624706

Abstract

In highly unstable diabetes (brittle diabetes) the degree of metabolic control called for today in managing the pregnant diabetic patient is not achievable by intensified conventional insulin therapy. These cases have been markedly improved by continuous insulin delivery systems. In the course of 2 years, 6 diabetic pregnant patients (8%) were treated with insulin pumps for a total of 910 days, using the intravenous route once, the intraperitoneal route twice and the subcutaneous route three times. The group consisted of one White C, one White D and four White R diabetic patients. Metabolic control was achieved by 5,916 blood sugar measurements, 42 determinations of glycosylated hemoglobin (HbA1) and 19 determinations of amniotic fluid insulin. The intravenous and the subcutaneous route showed about the same rate of hypoglycemia as intensified conventional insulin therapy. Hypoglycemia did not appear, however, under intraperitoneal insulin administration. Mean blood glucose in patients on the pump dropped from 121.0 to 97.4 mg/dl. The standard deviation of the blood glucose values during one week dropped from 64.5 to 35.2 mg/dl, the mean amplitude of glycemic excursions (MAGE) from 100 to 43 mg/dl and the mean of daily differences (MODD) from 72 to 29 mg/dl. The concentration of glycosylated hemoglobin sank from 10.5 to 6.8%. The metabolic condition improved significantly. On average, the patients were hospitalized for 7.5 (1.7-12.8) weeks. Fetal hyperinsulinism developed in 2 patients on the pump and was reversible by closer metabolic management. Neonatal weight was in the normal range and there were no signs of diabetogenic fetopathy.

References

  1. Diabetes Care. 1980 Mar-Apr;3(2):219-28 - PubMed
  2. Wien Klin Wochenschr. 1979 Apr 27;91(9):293-304 - PubMed
  3. Am J Obstet Gynecol. 1982 Oct 15;144(4):455-9 - PubMed
  4. Diabetes Care. 1982 May-Jun;5 Suppl 1:24-37 - PubMed
  5. Schweiz Med Wochenschr. 1981 Jul 25;111(30):1131-5 - PubMed
  6. Obstet Gynecol. 1978 Apr;51(4):393-8 - PubMed
  7. Z Geburtshilfe Perinatol. 1980 Jun;184(3):167-79 - PubMed
  8. Obstet Gynecol. 1984 Jul;64(1):65-8 - PubMed
  9. Am J Obstet Gynecol. 1978 Jan 15;130(2):228-30 - PubMed
  10. Diabetes. 1982 Mar;31(3):255-64 - PubMed
  11. Diabetes. 1970 Sep;19(9):644-55 - PubMed
  12. Obstet Gynecol. 1984 Jun;63(6):776-80 - PubMed
  13. Diabetes Care. 1982 Mar-Apr;5(2):140-1 - PubMed
  14. Diabetologia. 1974 Apr;10(2):139-43 - PubMed
  15. Pediatr Radiol. 1973 Oct;1(3):145-52 - PubMed
  16. Obstet Gynecol. 1984 Nov;64(5):629-37 - PubMed
  17. Lancet. 1978 Aug 5;2(8084):283-5 - PubMed
  18. Diabetes. 1979 Jul;28(7):640-5 - PubMed
  19. Lancet. 1979 Jun 30;1(8131):1372-3 - PubMed
  20. J Reprod Med. 1982 Oct;27(10):651-4 - PubMed

MeSH terms

Publication Types

LinkOut - more resources